Tender For Lab Kits/Reagents/Consumable Item For Blood Bank - 1 Anti A blood grouping (antiA monoclonal serum) -10 ML 1x10ml 2 ANTI A LECTIN -1X10 ML 1x10ml 3 ANTI AB ANTISERA.lXlO ML 1x10 ml 4 Anti B blood Brouping (anti B monoclonal serum)-10 ML 1x10ml 5 Anti D (Rn) blood Brouping serum -10 M- 1x 10rn I 6 ANTI H LECTIN.lXlO ML 1x 10m 1 Adhesive plaster 4 inch wide Each 8 EAND AlD ADH€SIVE STRIP 1x100 9 BLOOD WEIGHING MACHINE (0-1 kg) BOV NE ALBUM]N 1X10 ML COOMB5 ANTISERA 1X10 ML DOUBTE ELOOD 8AG LANCET Each 1x10ml tach Eaah 10 11 12 14 MULTI CHANNEL TIPS (0.5-10 uL-COMPATIBLE) -1x1000 15 MUtTI CHANNEL TIPS (10-100 uL-COMPATIBLE) -1X1000 1x1000Tips 16 MULII CHANNEL TIPS (30-300 uL-COMPATIBt.E) -lx1000 1x1000Tips 17 MULTT CHANNEL TIPS (50-50 ul- COMPATIBLE) -1X1000 1x1000Tips PEOIATRIC BLOOD 8AG 19 RPR/VDRL TEST KIT Each Test 20 RUBEER BALI FOR DONOR USE Each signal cPDA 350 Ml blood bag Elood collection bag made up of Each DEHP(Di-2-ethyihexylphthalate)plasticized PVc collapsible non vented sterile containers with collecting tube for completely closed system to avoid the chances of contaminating .single blood bag capacity -350m1. Needle-16 gauge ultra thin walled and straight . Blood bag tube should have multiple printed tD/segment numbers . (External port should be tamper proof and shouldnt be recapped .Anticoagulant -CPDA-1{49m1.)it should be clear & colour less.) 27 22 TISSUE PAPER ROLL Each TORNIQUET BELT Each Triple Blood bag 450 Ml with SAGM Mother bag of Triple blood Ea ch bag should have 450m1 capacity with 63ml CPD solution and is connected to one satellite transfer bag of 400m1 capacity and one satellite transfer bag of 400m1 with 100m1 sAGM. Mother bag should be 35mm to 50mm thlckness to prevent breakage during centrifugation and the inner diameter of the tLtbe shoold be standard measurement. Needle should be 16G with triple Bevel design to reduce penetration force and enable painless vain puncture. Blood bags and its packing should be properly labeled with batch no. Mfg date and date of expiry. Product labels should be bar-coded as per rule. Complies to l50 3825 and quality of components stored as per lndian Drugs and cosmetics act. for the manufacturers have to produce documentary evidence from the laboratories approved Government of lndia 2t wETGHTNG MACH rNE (0ONOR) Each 26 Disposable blue tips for microplpettes (2-200U1) -1x1000 1x1000Tips 1x1000Tips 21 Disposable yello tips for microplpettes (200-10010U1) 1x1000 28 Each 29 Each 24 31 Finn Pipette Variable Volume (100-1000 ul) Finn Pipette variable volume (10-100 ul) HBsAg Elisa Test Kit 4th Gen. HBsAg Elisa test kits (SpecificationSensitivity & Specificity should be100% must be able to detect 0.5 or less NG/ml.4th Generation HBsAG)- Test kits must have a long shelf life. oetects all known 11 sub-types of HBV and also mutant strains Can be used on any Manual/Semiautomatic System of Elisa. 1x96 Test. 4. The kit to be procured should have approval of the statutory authority in its country of origin. 5. ln case of imported kits it should have been registered and licensed in lndia by DCG (l). 6. ln case of indigenous manufacturers they shall have license issued bv the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centerS a roved DCG (r) HbsAg Rapid test kit (RAPID Test)4th gen. SpecificationSensitivity & Specificity 5hould be100% must be able to detect 0 L or le5s rU/ML . lt should Detects major vaccine escape mutants14T126N,T125S,Q129R,Q129HQ129L,M133H,M133L,K141 E,P142S,T143K,D144A,G145R,T123A,P120Q lt should have single step procedure,Subtype Serotype-A/H,A/E, A/ r,D / G,D I I,D / G Specimen : Serum/plasma, finger stick whole blood and vein puncture whole blood Hc-v trisatrt r,t, atG neratlon 11 Microplate ELISA coated with recombinant/synthetic peptrde / 7 32 antlgens for core, N53, N54 and NSs and antLbo to HCV core Antigen. 12. Adequate documents detailing the principle, components, bio-safety, methodologies, validity crileria, interpretation of results, performance characteristicS, storage conditions, limitation of assays, manufacturing & expiry dates 5hould be provided with each kit. 13. The kit to be procured should have approval of the statutory authority in its country of origin. 14. ln case of imported kits it should have been registered and licensed in lndia by DCG(l). 1.5. ln case of indigenous manufacturers they shall have license issued by the competgent authority defined under DruSs and Cosmetics Act 1940. After appropriate evaluation by the centers aPProved bY DCG(l). 16. The kit should have minimum shelf-life of 5/6$ or 12 months (whichever is more)atthe port ofdischarge ofconsignees 17. The assay component should include reactive (for both antibody and antigen) and non-reactive controls. 18. The assay should have a sensitivity more thanor equal to 1OO% and specificity of more than or equalto 98%. 19. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 20C-80c. The cumulative time temperature indicator technology used should be pre-qualified bY WHO and placed on every pack of kits. 20. The pack size should be 96 tests/kit HCV Rapid Dot Test (Must 8e 100% Sensitivity and up to 100%. - 4th Generation HCV Should be based on flow through technology Results in less than 3 minutes, HighlY purified HCV antigen! for core, N53, N54, N55 immobilized on the device). HCV should be able for the detect Ant core N53, N54, NS5 regions 34 12. Should be solid phase micro plate coated Hlv I & ll recombinant and/or synthetic peptide antigens and antibody to Hlv 1p 24. 13. The assay should detect HIV I and ll antibodies and HIV 1p24 antiSen. 14. Adequate documents detailing the principle, components, details of antigen lor antibodY detection of Hlv 1 and 2 and p24 Antigenm bio-safety, methodologies, validitycriteria, interpretation of results, performance characteri5ticS, storage conditions, limitatlon of assays, manufacturing & expiry dates should be provided with each kit. 15. The kat should have approval of the statutorY authority in its country of origin. 16. ln case of imported kits it should be registered and licensed under the provisions of Drugs & Cosmetics Act and rules and/or Medical Devices Rules 2017 in lndia. 17. ln case of indigenous manufacturers should be licensed under the provisions of DruSs & Cosmetics Act and rules or Medical Devices Rules 2017 issued bV the competent authority defined under Drugs and Cosmetics Act, 1940 18. The kit should have minimum remaining shelfolife of 5/6rh or 12 months (Whichever is more) at the port of discharge of con5ignee5. 19. The assay component should include reactive (for both antibody as well as antigen) and non-reactive controls with each kit.
